Fundraising Fox

Aptevo Therapeutics

NASDAQ: APVO

Seattle, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

ML
Marvin L WhiteExecutive

Investors · 2

HEALTHCARE ROYALTY PARTNERSNew York
Yorkville AdvisorsreportedMountainside

Reported raises · per SEC filings

Form D private placements

$2.1M disclosed across 1 of 2 rounds · 2025–2026

▶$2.1MraisedApr 2025 · 11 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Marvin L WhiteExecutive Officer, Director
Offering amount
$2.1M
Amount sold
$2.1M
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Aptevo Therapeutics (APVO) investors approve 2026 meeting agendastocktitan.net · Aug 2026Aptevo Therapeutics (NASDAQ:APVO) Posts Earnings Results, Beats Expectations By $0.70 EPS - Ticker Reporttickerreport.com · Aug 2026Aptevo's Mipletamig Shows 81% Remission in 31 Leukemia Patientsstocktitan.net · Aug 2026Aptevo Raises $4.5 Million Via Warrant Exercises and PIPE; Issues 5.6M Warrants at $4.03 — TradingView Newstradingview.com · Aug 2026Aptevo Therapeutics Raises Capital Through Warrant-Induced Financing - TipRanks.comtipranks.com · Aug 2026Aptevo Therapeutics Inc. (APVO) Stock: New Financing Targets $4.5M in Gross Proceedsblockonomi.com · Aug 2026

Frequently asked questions

Who are Aptevo Therapeutics's investors?
Aptevo Therapeutics's investors include HEALTHCARE ROYALTY PARTNERS, Yorkville Advisors.
How much funding has Aptevo Therapeutics raised?
Aptevo Therapeutics has disclosed $2.1M raised across 1 of its 2 known rounds.
Where is Aptevo Therapeutics headquartered?
Aptevo Therapeutics is headquartered in Seattle, US.